RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $50,868 | -20.5% | 295,578 | +100.0% | 0.00% | – |
| Q3 2022 | $64,000 | -49.2% | 147,789 | 0.0% | 0.00% | – |
| Q2 2022 | $126,000 | -97.7% | 147,789 | -85.1% | 0.00% | – |
| Q1 2022 | $5,478,000 | -73.9% | 994,127 | -54.2% | 0.00% | -100.0% |
| Q4 2021 | $21,011,000 | -50.2% | 2,170,537 | -7.9% | 0.00% | -50.0% |
| Q3 2021 | $42,150,000 | -29.2% | 2,357,385 | -3.4% | 0.00% | -33.3% |
| Q2 2021 | $59,568,000 | +250.2% | 2,440,295 | +280.2% | 0.00% | +200.0% |
| Q1 2021 | $17,010,000 | +236.1% | 641,886 | -3.7% | 0.00% | – |
| Q4 2020 | $5,061,000 | +49.8% | 666,740 | -1.1% | 0.00% | – |
| Q3 2020 | $3,379,000 | -17.2% | 674,461 | -1.1% | 0.00% | – |
| Q2 2020 | $4,079,000 | +39.6% | 682,024 | +3.9% | 0.00% | – |
| Q1 2020 | $2,922,000 | -53.6% | 656,555 | -1.0% | 0.00% | – |
| Q4 2019 | $6,301,000 | +28.4% | 663,278 | +6.1% | 0.00% | – |
| Q3 2019 | $4,908,000 | -48.6% | 625,218 | +2.9% | 0.00% | -100.0% |
| Q2 2019 | $9,555,000 | +3.2% | 607,417 | +18.8% | 0.00% | 0.0% |
| Q1 2019 | $9,257,000 | +212.0% | 511,458 | +177.1% | 0.00% | – |
| Q4 2018 | $2,967,000 | -20.6% | 184,545 | +18.5% | 0.00% | – |
| Q3 2018 | $3,737,000 | – | 155,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |